Does SUMATRIPTAN Cause Central nervous system lesion? 12 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Central nervous system lesion have been filed in association with SUMATRIPTAN (sumatriptan succinate). This represents 0.1% of all adverse event reports for SUMATRIPTAN.
12
Reports of Central nervous system lesion with SUMATRIPTAN
0.1%
of all SUMATRIPTAN reports
0
Deaths
4
Hospitalizations
How Dangerous Is Central nervous system lesion From SUMATRIPTAN?
Of the 12 reports, 4 (33.3%) required hospitalization.
Is Central nervous system lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUMATRIPTAN. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does SUMATRIPTAN Cause?
Drug ineffective (2,941)
Product physical issue (2,349)
Application site erythema (1,875)
Drug dose omission (1,711)
Product quality issue (1,269)
Application site pain (1,217)
Migraine (978)
Headache (914)
Product complaint (718)
Nausea (702)
What Other Drugs Cause Central nervous system lesion?
FINGOLIMOD (2,416)
DIMETHYL (1,152)
INTERFERON BETA-1A (978)
NATALIZUMAB (627)
DALFAMPRIDINE (561)
GLATIRAMER (492)
TERIFLUNOMIDE (315)
ADALIMUMAB (229)
OFATUMUMAB (185)
RITUXIMAB (151)
Which SUMATRIPTAN Alternatives Have Lower Central nervous system lesion Risk?
SUMATRIPTAN vs SUMATRIPTAN\SUMATRIPTAN
SUMATRIPTAN vs SUMAVEL DOSEPRO
SUMATRIPTAN vs SUNITINIB
SUMATRIPTAN vs SUNITINIB MALATE
SUMATRIPTAN vs SUTENT